Literature DB >> 1518888

Antitumor activity of patulin and structural analogs.

F Seigle-Murandi1, R Steiman, S Krivobok, H Beriel, J L Benoit-Guyod.   

Abstract

A comparison between the cytotoxicity and the antitumor activity of patulin and five structural analogs (isopatulin, dehydroisopatulin, dimethylisopatulin, trimethylisopatulin and isopropylisopatulin) has been established. In vitro assays using L 1210 and P 388 cells showed that the structure of the pyranic ring as well as the nature of the substituents influenced the observed activities. Among the five structural analogs of patulin assayed in vivo against Ehrlich carcinoma, L 1210 and P 388 leukemias, dehydroisopatulin was the only one to be active on all 3 types of tumors at a dose of 100 mg.kg-1.d-1. The ratio between the LD50 in mice and the active dose was 5 while with patulin it was 10. It can be assumed that the lactone function is not solely responsible for the activity of patulin and its structural analogs.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1518888

Source DB:  PubMed          Journal:  Pharmazie        ISSN: 0031-7144            Impact factor:   1.267


  3 in total

1.  Complementary cell-based high-throughput screens identify novel modulators of the unfolded protein response.

Authors:  Andrew M Fribley; Patricia G Cruz; Justin R Miller; Michael U Callaghan; Peter Cai; Neha Narula; Richard R Neubig; Hollis D Showalter; Scott D Larsen; Paul D Kirchhoff; Martha J Larsen; Douglas A Burr; Pamela J Schultz; Renju R Jacobs; Giselle Tamayo-Castillo; David Ron; David H Sherman; Randal J Kaufman
Journal:  J Biomol Screen       Date:  2011-08-15

2.  Antineoplastic activities of MT81 and its structural analogue in Ehrlich ascites carcinoma-bearing Swiss Albino mice.

Authors:  Sujata Maiti Choudhury; Malaya Gupta; Upal Kanti Majumder
Journal:  Oxid Med Cell Longev       Date:  2010 Jan-Feb       Impact factor: 6.543

3.  Identifying SARS-CoV-2 antiviral compounds by screening for small molecule inhibitors of nsp14/nsp10 exoribonuclease.

Authors:  Berta Canal; Allison W McClure; Joseph F Curran; Mary Wu; Rachel Ulferts; Florian Weissmann; Jingkun Zeng; Agustina P Bertolin; Jennifer C Milligan; Souradeep Basu; Lucy S Drury; Tom D Deegan; Ryo Fujisawa; Emma L Roberts; Clovis Basier; Karim Labib; Rupert Beale; Michael Howell; John F X Diffley
Journal:  Biochem J       Date:  2021-07-16       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.